Nitazene opioids and the heart: Identification of a cardiac ion channel target for illicit nitazene opioids
2024

Nitazene Opioids and Heart Risks

publication Evidence: moderate

Author Information

Author(s): Hancox Jules C., Wang Yibo, Copeland Caroline S., Zhang Henggui, Harmer Stephen C., Henderson Graeme

Primary Institution: University of Bristol

Hypothesis

Do nitazene opioids inhibit the hERG potassium channel, posing cardiac risks?

Conclusion

Nitazene opioids are predicted to inhibit the hERG channel, indicating a potential risk for cardiac arrhythmias.

Supporting Evidence

  • All nitazenes were predicted to inhibit hERG with low μM IC50 values.
  • Predictions indicate a potential for proarrhythmic hERG block by nitazene opioids.
  • Previous studies have linked methadone and other opioids to QT prolongation.

Takeaway

Nitazene opioids might mess with your heart by blocking a key channel, which could lead to serious heart problems.

Methodology

Machine-learning tools were used to evaluate the interaction of five nitazene compounds with the hERG potassium channel.

Potential Biases

Potential bias due to reliance on computational predictions without in vitro validation.

Limitations

The study focuses solely on hERG and does not assess interactions with other cardiac channels.

Digital Object Identifier (DOI)

10.1016/j.jmccpl.2024.100118

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication